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ABSTRACT 
 A link between exposure to ultraviolet (UV) radiation and melanoma skin cancer 
formation has generally been accepted in the scientific community, but precise 
quantification of such a link into a predictive equation is difficult to find in scientific 
literature.  It was the aim of this study to determine if a quantifiable relationship exists 
between UV exposure and melanoma rates in the United States.  Prior to the initiation of 
this study, it was hypothesized that existing predictive equations using accumulated UV 
index and latitude for general skin cancer incidence (i.e., including both melanoma and 
non-melanoma skin cancers) in Chile would be effective in predicting melanoma 
incidence rates in the United States.  It was also hypothesized that melanoma rates for 
specific locations in the United States are related to the latitudes and accumulated UV 
index values for those locations, respectively.  After accumulated UV index values, 
latitudes, and melanoma incidence rates for locations across the United States were 
obtained, regression analyses were performed in Microsoft Excel 2010
®
 between 
accumulated UV index, latitude, and melanoma incidence rates for all demographic 
groups combined as well as differing demographic groups.  The Chilean skin cancer 
equations (Rivas equations) were found to have no predictive power for melanoma rates 
in the United States.  The only demographic group which had a significant relationship 
with accumulated UV index and latitude was American Indian or Alaska Native.  For the 
remaining ethnicities, the regression analyses failed to reject the null hypotheses.  Due to 
a variety of confounding variables and the limitations of the available data, a quantifiable 
relationship between UV exposure and melanoma might be determined only by more 
complex methodology.  Factors such as skin color variation within each listed ethnicity, 
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differences in UV exposure patterns between individuals, and inconsistent reporting to 
cancer registries by dermatologists may preclude the formation of simple predictive 
equations for melanoma incidence.  Future research which incorporates individuals’ 
behaviors (e.g., time spent in the sun) may have more success. 
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INTRODUCTION 
 Melanoma is a cancer of the melanocytes and is the deadliest form of skin cancer.  
Melanocytes are specialized skin cells located in the epidermis which produce melanin, a 
pigment responsible for determining the color of human skin as well as protecting it from 
harmful ultraviolet rays (Hearing, 2011).  Melanoma occurs when melanocytes 
proliferate uncontrollably, and may arise either from a pre-existing mole or with no 
apparent warning (American Academy of Dermatology, n.d.).  According to Weir et al. 
(2011), melanoma often metastasizes (i.e., spreads to distant organs) and can prove to be 
lethal, but if caught early it has a very good prognosis.  The authors did not specify what 
constitutes “early” nor did they include the precise prognosis at early stages.  However, 
Weir et al. (2011) were likely referring to stage IA of the disease, in which the tumor is 
less than 1 mm thick and the 5-year survival rate is 97 percent (National Cancer Institute, 
“Stages of melanoma,” n.d.; American Cancer Society, 2014). 
 In the United States, 921,780 people live with melanoma, and two percent of men 
and women will be diagnosed with the condition at some point in their lives (National 
Cancer Institute, “Surveillance, Epidemiology, and End Results (SEER) cancer statistics 
fact sheets,” n.d.).  It is estimated that 76,100 new melanomas will be diagnosed and 
9,710 people will die from melanoma in the United States in 2014 (American Cancer 
Society, 2014).  Melanoma is much less common than other skin cancers, accounting for 
less than two percent of all cases, but it causes the vast majority of skin cancer deaths 
(American Cancer Society, 2014).   
 Basal cell and squamous cell carcinomas are the two most common skin cancers, 
accounting for 3.5 million skin cancers in 2.2 million Americans each year, with the 
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majority of these being basal cell carcinomas (American Cancer Society, 2014).  They 
are cancers of the keratinocytes, which are keratin-producing cells that make up the 
predominant cell type in the epidermis (Eckert and Rorke, 1989).  Unlike melanoma, 
which spreads and metastasizes fairly rapidly, basal and squamous cell carcinomas are 
slow-growing and rarely metastasize (Stulberg et al., 2004).  Since the prognosis of non-
melanoma skin cancers is so much better than that of melanoma, it is critical that a 
distinction be maintained between the two in order to avoid confusion.  Thus, the 
overarching term “skin cancer” is of limited usefulness.  Even published papers forget to 
make the necessary distinction (e.g., Rivas et al., 2012). 
 Melanoma is most common in the elderly.  The median age at melanoma 
diagnosis is 61, and the highest incidence is in people 55 to 64 years of age (National 
Cancer Institute, “SEER cancer statistics factsheets,” n.d.).  The median age for 
melanoma deaths is 69, and death rates for melanoma are highest in those 75 to 84 years 
of age (National Cancer Institute, “SEER cancer statistics factsheets,” n.d.).  Melanoma 
affects elderly people considerably more than young people, but it is quite prevalent 
among young people as compared to other cancers.  It is the second most common cancer 
in adolescents and young adults under the age of 30 in the United States and the most 
common for those ages 25 to 29 (Weir et al., 2011; Skin Cancer Foundation, 2013).   
 Patterns of melanoma incidence differ markedly between males and females.  
Melanoma rates are considerably higher for men than women, with one in 35 males and 
one in 54 females acquiring melanoma in their lifetime (American Cancer Society, 
“Cancer facts and figures,” 2013).  Women under 40 are twice as likely to get melanoma 
as men, but after age 40 men have a higher rate and at 80 years and older the rate is three 
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times that in women the same age (American Cancer Society, “Cancer facts and figures,” 
2013).  While younger women have a higher incidence of melanoma than men, young 
men often have more severe cases.  For those ages 15 to 39, the higher melanoma 
incidence among women is confined to thin lesions, which are less than one millimeter 
thick (Jemal et al., 2011).  Young men have a 55 percent lower survival rate than young 
women, comprising 40 percent of the cases but 60 percent of the deaths in ages 15 to 39 
(Fisher and Geller, 2013).   
 Melanoma disproportionately affects Caucasian individuals, but other ethnicities 
have a larger proportion of severe and deadly cases (Gloster and Neal, 2006).  Caucasians 
are twenty times more likely than African Americans to have a melanoma, but African 
Americans appear to have a greater ratio of melanoma to non-melanoma skin cancers 
than whites do (Gilchrest et al., 1999; Moan et al., 1999).  Non-Caucasian patients often 
get diagnosed with melanoma at a more advanced stage of the disease.  In a retrospective 
study of residents of Miami-Dade county, Florida, 52 percent of non-Hispanic black 
patients, 27 percent of Hispanic patients, and only 16 percent of non-Hispanic white 
patients received an initial diagnosis of late-stage melanoma (Hu et al., 2006).  Moreover, 
non-Caucasians account for 6.5 percent of pediatric melanomas, which is a higher 
proportion than that in adults (Skin Cancer Foundation, 2013).  Whereas melanomas in 
Caucasians most often appear on areas exposed to the sun, melanomas in African 
Americans, Asians, Filipinos, Indonesians, and Native Hawaiians generally occur on 
areas with less pigment and not often exposed to the sun, such as the skin of their nail 
beds, soles of the feet, palms, and mucous membranes (Gloster and Neal, 2006; Gilchrest 
et al., 1999). 
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 It is unclear precisely how a normal melanocyte becomes a melanoma cell, but 
melanoma is thought to be preceded by an accumulation of mutations, many of which 
have been identified (Weir et al., 2011).  Approximately 50 to 65 percent of melanomas 
have mutations that overactivate the BRAF gene, which codes for a protein involved in 
cell signaling and proliferation, and twenty percent of melanomas have mutant overactive 
NRAS, a GTPase involved in regulating cell division (National Institutes of Health, 2014; 
Uong and Zon, 2010).  Since these mutations are found in melanoma tissue and the wild-
type versions are found in normal tissue from the same patients, the mutations seem to be 
somatically acquired (Uong and Zon, 2010).    
 Other melanoma-associated mutations are heritable, such as germ-line mutations 
in the CDKN2A locus and certain variants in the polymorphic MC1R gene (Goldstein et 
al., 2005).  CDKN2A is a prominent tumor suppressor gene, and MC1R codes for a 
hormone receptor and is significantly involved in pigmentation (National Institutes of 
Health, 2014).  CDKN2A is considered a “high risk” mutation for melanoma production, 
and approximately twenty percent of melanoma patients have CDKN2A mutations 
(Goldstein et al., 2005).  Though a “low risk” mutation for melanoma formation, 
variation in the MC1R gene is commonly seen in patients with melanomas (Goldstein et 
al., 2005).  In a French study, loss-of-function MC1R variants were found in 68 percent 
of patients and only 31 percent of controls, thus illustrating that while such variants are 
common in normal individuals they are much more prevalent in those with melanomas 
(Matichard et al., 2004).   
 A major causal factor for most melanomas appears to be exposure to ultraviolet 
(UV) radiation, which is the most abundant environmental carcinogen (Bhattacharyya et 
5 
 
al., 2013).  Ultraviolet radiation has been divided into three major categories based on 
wavelength:  UVA (320 – 400 nm), UVB (290 – 320 nm), and UVC (less than 290 nm) 
(Ikehata and Ono, 2011).  UVA is the weakest band and is known to cause premature 
aging in skin cells as well as indirect damage to DNA (American Cancer Society, “What 
is UV radiation?” 2013).  UVB radiation is higher energy and directly damages the DNA 
in the skin, causes sunburn, and is thought to play more of a role in skin cancer formation 
than UVA (Skin Cancer Foundation, n.d.).  The ozone layer completely blocks out UVC 
radiation, and in fact it filters out most UVB radiation but not UVA (World Health 
Organization, n.d.).  Unlike the higher energy wavelengths of ionizing radiation, UVA 
and UVB radiation are not able to penetrate deeply into the body, and thus they primarily 
affect the skin (American Cancer Society, “What is UV radiation?” 2013).  More 
specifically, UVB radiation almost exclusively impacts the epidermis while UVA affects 
the dermis and basal layer of the epidermis (Skin Cancer Foundation, n.d.).   UVB, most 
often in the form of sunlight, has a strong tendency to damage DNA in the skin (Ikehata 
and Ono, 2011).  Both UVA and UVB radiation introduce two types of DNA lesions into 
the double helix — cyclobutane pyrimidine dimers and 6-4 photoproducts — which 
hamper replication and transcription by causing kinks or bends in DNA (Clancy, 2008).  
Throughout most of the lifespan, humans’ repair mechanisms are able to fix the damage 
via nucleotide excision repair and other methods (Clancy, 2008).  However, when repair 
mechanisms fail, mutations may result, which could eventually lead to a melanoma.  
Throughout the remainder of this paper, “UV” refers to both UVA and UVB radiation 
unless otherwise specified.   
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 The pattern of UV exposure also appears to have major implications for 
melanoma formation.  Intermittent, rather than chronic or occupational exposure, seems 
to carry the greatest risk (Elwood and Jopson, 1997).  Intermittent exposure is likely more 
dangerous because after absence from significant UV exposure, the skin has a lower 
melanin content, and thus the melanocytes are unprotected from the genotoxic effects of 
UV radiation (Gilchrest et al., 1999).  It may be inferred that three weeks of absence from 
UV exposure is the period of time after which the skin starts to lose melanin content, 
since three weeks is how long a moderate tan persists in most people after being exposed 
to a single, sunburn-inducing dose of UV radiation (Gilchrest et al., 1999).  In individuals 
who are able to tan, UV exposure stimulates melanin synthesis which persists for days, 
and it may take weeks or even months for the skin to return to its normal color (Brenner 
and Hearing, 2008).  Thus, individuals who are exposed to the sun regularly and are able 
to tan have an enhanced degree of photoprotection (Brenner and Hearing, 2008).  
Additionally, many studies have shown a positive correlation between history of sunburn 
and melanoma (Gandini et al., 2005).  
 The average minimum ozone levels for 2013 (133 Dobson Units) were less than 
in 1979 (225 Dobson Units), the first year that comprehensive ozone measurements were 
available (National Aeronautics and Space Administration, 2014).  The ozone layer has 
thinned due to ozone depletion caused largely by chlorine and bromine based chemicals, 
thus more UVB radiation reaches the ground than previously (National Aeronautics and 
Space Administration, 2014).  In addition to the absorptive power of the ozone layer, 
another factor significantly affecting the UV intensity is the angle of the sun, and this is 
influenced by time of day, season, and latitude (U.S. Environmental Protection Agency, 
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2014).  The sun is at its maximal angle for a given area at solar noon (i.e., when the sun is 
at its highest point) and during the summer months (University of California, Santa 
Barbara, n.d.).  The angle of the sun at solar noon decreases with increasing latitudes 
(University of California, Santa Barbara, n.d.).  Moreover, cloud cover and altitude help 
determine how much UV radiation reaches the ground (World Health Organization, n.d.).  
Scattered clouds transmit 89 percent of UV radiation, broken clouds allow 73 percent, 
and overcast skies transmit only 31 percent (Environmental Protection Agency, 2014).  
UV radiation reaching the ground increases roughly ten percent with every 1000 meter 
increase in altitude (World Health Organization, n.d.).  In order to quantify many of the 
factors listed above into a single whole number which could be easily understood by the 
public, Canada introduced the UV index in 1992 (Fioletov et al., 2010).  The UV index 
ranges from one (mild) to eleven or more (extreme), and it takes into account ozone 
levels, sunlight angle, cloud cover, and UV strength weighted towards the  UV 
wavelengths that cause the most damage to human skin (Environmental Protection 
Agency, 2014).   
 Though there is a strong body of evidence suggesting that UV exposure helps 
bring about both melanoma and non-melanoma skin cancers, there is a dearth of studies 
offering an explicit quantitative relationship between UV strength and skin cancer 
incidence or a predictive equation based on those variables.  However one Chilean paper 
offered simple, explicit predictive equations.  In a study of Chilean skin cancer rates, 
Rivas et al. (2012) formed predictive equations relating latitude with skin cancer 
incidence [Skin Cancer Incidence = 45.718-0.753*(Latitude)], and accumulated UV 
index with skin cancer incidence [Skin Cancer Incidence = 5.019+0.336*(UV index)].  
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The Rivas equations were developed using incidence data that included both melanoma 
and non-melanoma skin cancers (Rivas, pers. comm., 2013).   
 In the absence of any useful predictive models for skin cancer for the United 
States, I sought to test the reliability of the Rivas equations in determining melanoma 
rates in the U.S.  Melanoma incidence was used instead of general skin cancer incidence 
because non-melanoma skin cancers are not reported to cancer registries in the United 
States (Rogers et al., 2010).  I developed the following null hypotheses:  (1) The first 
Rivas equation relating skin cancer incidence and latitude does not have predictive power 
for United States melanoma incidence data; (2) The second Rivas equation relating skin 
cancer incidence and accumulated UV index does not have predictive power for United 
States melanoma incidence data; (3) Melanoma incidence rates for specific locations in 
the United States are unrelated to the latitudes of those locations; (4) Melanoma 
incidence rates for specific locations in the United States are unrelated to the accumulated 
UV index values for those locations.   
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MATERIALS AND METHODS 
Data Sources 
 UV indices of cities across the country were obtained from National Oceanic and 
Atmospheric Administration (NOAA) National Weather Service “UV Index: Annual 
Time Series” (n.d.).  Cities used in this study were those found in the NOAA (n.d.) UV 
index dataset.  Average accumulated UV index for the years 2006 to 2010 was calculated 
for each city.  Following Rivas’s methodology, average accumulated UV index for a 
particular year is calculated by adding up the monthly means of the maximal daily UV 
index values (Rivas, pers. comm., 2013).  This calculation was carried out for each year 
from 2006 to 2010, and the resulting values were averaged.   
 Latitudes were acquired for each city through Google Maps (2014).  The city 
latitudes were used for melanoma incidence data that were specific to a county, city, or 
metropolitan area.  For state-wide melanoma incidence data, I obtained the latitude of 
each state’s geographic center from About.com Geography (Rosenberg, n.d.).  Latitudes 
in degrees and minutes were converted to decimal form for easier graphing by dividing 
the minutes by 60.   
 Melanoma incidence refers to the rate per 100,000 inhabitants.  The age-adjusted 
melanoma incidence data for each county encompassing each listed city were obtained 
from the Centers for Disease Control’s (CDC) (2013) online tool “U.S. County Cancer 
Incidence Dataset” except for the county incidence data for Kansas, which was not 
available in that dataset, and Virginia, for which there was only statewide data in the 
dataset.  The county melanoma incidence data for Kansas was obtained from the Kansas 
Cancer Registry (2012).  Statewide melanoma incidence data from the CDC (2013) tool 
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was used for Virginia.  Cities in the UV index dataset whose counties or states did not 
have melanoma incidence data on CDC’s (2013) incidence dataset or data with the proper 
years (2006-2010) on their state cancer registry websites were excluded from the study.  
The majority of the cities were located wholly within a county and thus county-wide data 
is used for the listed cities.  In some cases, a city was either its own county or an 
independent municipality.  For cities located in more than one county, the most populous 
county was used.  In the case of New York City, which is composed of five prominent 
counties, New York county (i.e., Manhattan) was selected because it is the nearest to the 
listed latitude of New York City.  See Table 1 for a list of the specific counties and 
independent cities for which I found incidence data.  For each area, I found melanoma 
incidence for both genders combined and separated for all ethnicities combined and for 
whites, Hispanic included.  Even though this data includes incidence values from some 
independent cities as well as the statewide incidence for Virginia, I will refer to it as 
county melanoma incidence data. 
 With one exception, I obtained age-adjusted melanoma incidence data for a 
greater number of ethnicities using the “Fast Stats” tool from the North American 
Association of Central Cancer Registries (NAACCR) (2012).  I used the New York 
Cancer Registry (2012) to acquire such data for Manhattan.  Both NAACCR data and 
New York State Cancer Registry incidence data were for the years 2006 to 2010.  The 
majority of the data was statewide, but I utilized metropolitan and city-specific data 
where available.  Areas for which I found metropolitan or city-specific data are as 
follows:  New York City, NY (Manhattan specific), Washington, D.C., San Francisco, 
CA, Los Angeles, CA, and Atlanta, GA.   
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 Concerning statewide melanoma incidence data, the majority of states used had 
only one city with available UV index values.  For these, I used the UV index data for the 
listed city.  Texas, Florida, and Pennsylvania each had statewide melanoma incidence 
data, but they had multiple cities with UV index data.  For these, I used the UV index 
data for the city closest to the state’s geographic center.   
 With regard to each state, metropolitan area, or city, I found melanoma incidence 
for genders combined and separated for each of the following ethnicities:  white non-
Hispanic, Asian or Pacific Islander, African American, Hispanic, and American Indian or 
Alaska Native.  In addition, I found age-specific melanoma incidence data for U.S. males 
and females from NAACCR (2012).  The age groups are as follows:  less than one, one to 
four, ages five to 84 in five year increments, and 85 and older. 
Data Analyses 
 The following data analyses were all performed in Microsoft Excel 2010
®
.  
Unless otherwise specified, melanoma incidence encompasses both genders and all 
ethnicities.  Estimated skin cancer incidence rates were calculated by entering U.S. city 
latitudes and accumulated UV index values into the first and second Rivas equations, 
respectively.  For each equation, a simple linear regression analysis was performed of 
melanoma incidence (using county melanoma incidence data) against estimated skin 
cancer incidence.   
 In order to examine the strength of the relationship of accumulated UV index and 
latitude in the United States, a simple linear regression analysis was performed of average 
accumulated UV index, 2006-2010, against city latitude.  For Virginia, the latitude of the 
state geographic center was used instead.  Simple linear regression analyses of melanoma 
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incidence against accumulated UV index and melanoma incidence against latitude were 
carried out in order to separately evaluate the relationship of each variable with 
melanoma incidence.  A simple linear regression analysis was performed of melanoma 
incidence against male melanoma incidence to investigate the contribution of males to the 
total melanoma incidence.  A simple linear regression analysis of female melanoma 
incidence against latitude was carried out to see if female incidence had a different 
relationship with latitude than the total melanoma incidence.  The following multiple 
linear regressions were carried out in order to investigate possible differences in the 
relationships between accumulated UV index, latitude, and melanoma incidence among 
varying demographic groups.  Multiple linear regression analyses were performed for 
melanoma incidence and white including Hispanic melanoma incidence (genders 
combined and separated), respectively, against accumulated UV index and latitude.  The 
preceding regression analyses all used county melanoma incidence data.  For the state, 
city, and metropolitan data from NAACCR (2012) and the New York Cancer Registry 
(2012), multiple regression analyses were performed for melanoma incidence data 
(genders combined and separated) of the following demographic groups against 
accumulated UV index and latitude:  white non-Hispanic, Asian or Pacific Islander, 
African American, Hispanic, and American Indian or Alaska Native.  
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RESULTS 
 The melanoma incidence data had a significant relationship with the estimated 
skin cancer incidence produced by the first Rivas equation (Figure 1) and a nearly 
significant relationship with that of the second Rivas equation (Figure 2).  Simple linear 
regression analyses revealed significant relationships in the following pairs of variables:  
accumulated UV index and latitude (Figure 3); melanoma incidence and male melanoma 
incidence (Figure 4); melanoma incidence and latitude (Figure 5); female melanoma 
incidence and latitude (Figure 6).  The simple linear regression analysis of melanoma 
incidence against accumulated UV index showed a nearly significant relationship 
between the two variables (Figure 7).  Multiple regression analyses using county data 
revealed insignificant relationships of melanoma incidence with accumulated UV index 
and latitude for all groups (Table 2).   
 Multiple regression analyses using state, city, and metropolitan data revealed a 
statistically significant or nearly significant relationship of melanoma incidence against 
accumulated UV index and latitude in American Indian or Alaska Native combined 
gender (Figure 8), male (Figure 9), and female (Figure 10).  The melanoma incidence 
rates of the remaining demographic groups displayed insignificant relationships with 
accumulated UV index and latitude (Table 3). 
 On the age group graph (Figure 11), females had a higher melanoma incidence 
than men until 50-54, after which point the male rates surpassed them.  The rate for 
females increases steadily until 85 and older, when the rate shows a slight decrease.  The 
male incidence rates increase much more rapidly throughout life, and each age group has 
a significantly higher incidence than the preceding one. 
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DISCUSSION 
 Though the skin cancer incidence values predicted by the first Rivas equation had 
a significant relationship with U.S. melanoma incidence, the correlation was weak due to 
a low r
2
 value.  Furthermore, the first Rivas equation predicted a negative value for 
incidence at one point, which is an undesirable result since incidence by nature cannot be 
negative.  The first Rivas equation may be an unreliable predictor in part because it was 
designed from only four data points (Rivas et al., 2012).  The skin cancer incidence 
predicted by the second Rivas equation also had a weak relationship with U.S. melanoma 
incidence as evidenced by the low r
2
 value.  The second Rivas equation was designed 
from fourteen data points, which is likely still too few to form a reliable predictive 
equation (Rivas et al., 2012).  One would expect Figures 1 and 2 to both show positive 
rather than negative relationships since melanoma and skin cancer rates would be 
expected to be positively correlated.  However, the main importance of each graph is that 
they show the Rivas equations do not work well to predict melanoma rates in the U.S.  
Because the r
2
 values are so low in both figures, the direction of the linear fit is not very 
meaningful.  The Rivas equations were designed with general skin cancer incidence data, 
so perhaps if U.S. general skin cancer incidence had been available to use, the results 
would have been more highly correlated.  Since the Rivas equations were poor predictors 
for melanoma rates in the U.S., the first two null hypotheses were not rejected.   
 Accumulated UV index and latitude were shown to have a significant and strong 
inverse relationship, which corroborates the idea that lower latitudes receive higher UV 
levels.  Male melanoma incidence had a strong relationship with melanoma incidence.  It 
seems likely that males have a greater total contribution to overall melanoma incidence 
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due to the higher rates for males, but it would be helpful to carry out a simple linear 
regression analysis of melanoma incidence against female melanoma incidence in order 
to verify this hypothesis.  The relationship of melanoma incidence against latitude was 
marked by a low r
2
 value, whereas the regression of female melanoma incidence against 
latitude had a higher r
2
 value.  This may suggest that female melanoma incidence occurs 
more along a latitude gradient than that of males, but a simple linear regression analysis 
of male melanoma incidence against latitude should be carried out in order to substantiate 
this hypothesis. 
 Across all demographic groups except American Indian or Alaska Native, data 
were marked by poor relationships between incidence, accumulated UV index, and 
latitude.  The third and fourth null hypotheses were only rejected by the data for the 
American Indian or Alaska Native ethnicity category.  The combined gender American 
Indian or Alaska Native contained somewhat strong relationships with accumulated UV 
index and latitude as seen by their moderate r
2
 values.  Female American Indian or 
Alaska Native melanoma incidence had a strong correlation between the variables due to 
a high r
2
 value but the relationship was not quite significant.  This lack of significance 
may have stemmed from the fact that there were only six data points for female American 
Indian or Alaska Native melanoma incidence, which is less than that of either combined 
gender (n = 11) or male (n = 8) incidence for that demographic group.  Perhaps American 
Indians and Alaska Native males and females have somewhat homogeneous habits of sun 
exposure and sun protection stemming from a relative uniformity of lifestyle.  Moreover, 
they may be more prone to live in one location throughout life and may travel less 
frequently than other demographic groups.  The previous two hypotheses, if statistically 
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supported, may account for a reduction in confounding variables in the data, and thus a 
stronger relationship between melanoma incidence, latitude, and accumulated UV index. 
 Male and female melanoma incidence rates in the U.S. may differ due to 
behavioral and biological differences.  The higher melanoma rates of females in their 
teens and twenties may be related to the fact that adolescent girls are more likely than 
other groups to tan indoors (Buller et al., 2011).  Conversely, females tend to engage in 
sun-protective behaviors more often than males, which may explain the higher rates in 
males later in life (Buller et al., 2011).  Furthermore, there may be differences between 
the sexes in biological traits such as skin thickness or melanocyte physiology which 
might contribute to the different rate patterns. 
 The lack of a significant correlation between melanoma incidence, accumulated 
UV index, and latitude does not rule out UV exposure as a major risk factor for 
melanoma.  Indeed, since intermittent patterns of UV exposure seem to carry a higher 
melanoma risk than chronic patterns, one would not expect there to be a clear correlation 
between incidence and the other two variables.  Since those in areas of higher latitude and 
lower average UV index would historically have less melanin than those in areas of 
greater sun exposure, they are less protected from UV radiation.  Thus, when those 
individuals with lower amounts of melanin receive a high dose of UV radiation on an 
unusually bright day, a vacation to a tropical area, or hours in a tanning bed, their 
melanocytes are more vulnerable to UV damage than individuals who have been more 
regularly exposed.  Indeed, Elwood and Diffey (1993) calculated that individuals at 
higher latitudes (50 to 55
o
 N) receive 33 percent of their total UVB exposure as 
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intermittent exposure while those at lower latitudes (15 to 27
o
 S) receive only 23 percent 
as intermittent exposure. 
 This study had several limitations.  Movement of peoples was not accounted for, 
namely immigration and vacations.  It is possible that a person may have received the 
bulk of his or her UV exposure from previous locations before moving to the location 
where he or she received the diagnosis.  Furthermore, people in high latitudes with low 
UV levels may receive a large amount of their exposure from vacations in sunnier areas.  
Another major factor which this study did not fully account for is genetic variation.  
Some populations, even within the same listed ethnic group, may naturally have skin with 
higher melanin content than others.  For instance, areas with a large concentration of 
inhabitants of Nordic or Scots-Irish ancestry may have significantly different rates than 
those with large populations of Mediterranean ancestry, but these populations would all 
be listed in the cancer registries as non-Hispanic white.  Perhaps the largest setback for 
this and any similar study is the possibility that melanoma diagnoses are considerably 
under-reported by physicians.  A survey administered to dermatologists attending the 
Cutaneous Oncology Symposium in 2010 found that 50 percent of the respondents did 
not know they were obligated to report new melanoma diagnoses to their state cancer 
registry, and 56 percent did not report or did not know how to report the new diagnoses 
(Cartee et al., 2011).  Since many melanoma cases may go unreported, it is possible that 
the rates of reporting diagnoses vary in different areas.  Thus, any study comparing 
melanoma incidence rates between areas faces a serious disadvantage.   
  More reliable sun exposure and behavioral data is needed before any definite 
conclusions can be formed about the relationship of UV exposure to melanoma rates.  
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Future studies may do well to incorporate data from wearable fitness devices that track 
information such as steps and miles.  The popularity of such devices is growing, and nine 
percent of people owned a wearable fitness device in 2013 (Dahl, 2014).  Studies could 
use data from the devices of active users to measure time spent in the sun in order to 
make a more accurate estimate of UV exposure.  However, in order to ensure that future 
melanoma studies are meaningful, dermatologists must report all melanoma diagnoses to 
the state cancer registries.  Perhaps this could be achieved by more thorough education of 
the responsibility to report to registries in dermatology residency programs for upcoming 
dermatologists and through continuing medical education for currently practicing ones. 
 The relationship of melanoma formation to UV exposure is complex, but it merits 
further research.  Melanoma is one of the most common cancers, it can frequently be 
deadly, and its incidence is growing, with rates rising an average of 2.6 percent a year for 
the past ten years (National Cancer Institute, “SEER cancer statistics factsheets,” n.d.).  
Groundbreaking new treatments for advanced stage melanoma such as molecularly 
targeted treatments and immunotherapies provide a more promising future for melanoma 
patients, but more work is desperately needed on the prevention front (Melanoma 
Research Alliance, n.d.).  In order to effectively address this worrisome increasing 
incidence trend and provide accurate prevention information to the public, the scientific 
community needs to gain a more complete understanding of how UV exposure affects 
melanoma formation.  As shown by this study, simple relationships between melanoma 
rates and UV exposure may not exist.  A more nuanced approach which takes into 
account a number of demographic, behavioral, and environmental factors is warranted. 
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Table 1.  List of counties used for county-specific melanoma incidence data.  The boxes 
with a dash are for cities which are independent or have the same boundaries as the 
county. 
 
City County 
Mobile, AL Mobile 
Anchorage, AK - 
Phoenix, AZ Maricopa 
Little Rock, AR Pulaski 
Los Angeles, CA Los Angeles 
San Francisco, CA - 
Denver, CO - 
Hartford, CT Hartford 
Washington, DC - 
Dover, DE Kent 
Jacksonville, FL Duval 
Miami, FL Miami-Dade 
Tampa, FL Hillsborough 
Atlanta, GA Fulton 
Honolulu, HI - 
Boise, ID Ada 
Chicago, IL Cook 
Indianapolis, IN Marion 
Des Moines, IA Polk 
Wichita, KS Sedgwick 
Louisville, KY Jefferson 
New Orleans, LA - 
Baltimore, MD - 
Boston, MA Suffolk 
Detroit, MI Wayne 
Jackson, MS Hinds 
St. Louis, MO - 
Billings, MT Yellowstone 
Omaha, NE Douglas 
Las Vegas, NV Clark 
Concord, NH Merrimack 
Atlantic City, NJ Atlantic 
Albuquerque, NM Bernalillo 
Buffalo, NY Erie 
New York City, NY New York 
Raleigh, NC Wake 
Bismarck, ND Burleigh 
Oklahoma City, OK Oklahoma 
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Table 1 (cont.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portland, OR Multnomah 
Philadelphia, PA - 
Pittsburgh, PA Allegheny 
Providence, RI Providence 
Charleston, SC Charleston 
Sioux Falls, SD Minnehaha 
Memphis, TN Shelby 
Dallas, TX Dallas 
Houston, TX Harris 
Salt Lake City, UT Salt Lake 
Burlington, VT Chittenden 
Norfolk, VA ***statewide data used*** 
Seattle, WA King 
Charleston, WV Kanawha 
Milwaukee, WI Milwaukee 
Cheyenne, WY Laramie 
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Table 2.  Results of the multiple regression analysis of age-adjusted melanoma incidence 
per 100,000 of varying demographic groups against average accumulated UV index, 
2006-2010, and latitude.  County melanoma incidence data, 2006-2010. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Variables F-stat P-valueUVI P-valueLatitude r
2 
Combined gender, 
Combined ethnicity 
2.10 0.742 0.2976 0.0760 
Combined gender,  
White incl. Hispanic 
0.729 0.899 0.747 0.0278 
Male, 
White incl. Hispanic 
2.44 0.707 0.655 0.0874 
Female, 
White incl. Hispanic 
0.136 0.633 0.711 0.00530 
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Table 3.  Results of the multiple regression analysis of age-adjusted melanoma incidence 
per 100,000 of varying demographic groups against average accumulated UV index, 
2006-2010, and latitude.  State and metropolitan melanoma incidence data, 2006-2010. 
 
 
 
 
Variables F-stat P-valueUVI P-valueLatitude r
2 
Combined gender, 
White non-Hispanic 
6.62 0.0646 0.554 0.231 
Male, 
White non-Hispanic 
9.17 0.0396 0.380 0.290 
Female, 
White non-Hispanic 
3.02 0.364 0.412 0.118 
Combined gender, 
Asian or Pacific Islander 
0.272 0.704 0.845 0.0252 
Male, 
Asian or Pacific Islander 
0.491 0.697 0.534 0.0702 
Female, 
Asian or Pacific Islander 
0.238 0.905 0.959 0.0296 
Combined gender, 
African American 
0.429 0.544 0.947 0.0287 
Male, 
African American 
0.731 0.572 0.890 0.0574 
Female, 
African American 
0.288 0.518 0.771 0.0217 
Combined gender, 
Hispanic 
0.0256 0.855 0.825 0.00142 
Male, 
Hispanic 
0.0722 0.989 0.786 0.00436 
Female, 
Hispanic 
0.0841 0.764 0.984 0.00478 
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Figure 1.  Simple linear regression of age-adjusted melanoma incidence per 100,000 
inhabitants against skin cancer incidence estimated via 1
st
 Rivas equation [Skin Cancer 
Incidence = 45.718-0.753*(Latitude)].  County melanoma incidence data, 2006-2010.     
F = 4.16, p = 0.0466. 
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Figure 2.  Simple linear regression of age-adjusted melanoma incidence per 100,000 
inhabitants against skin cancer incidence estimated via 2
nd
 Rivas equation [Skin Cancer 
Incidence = 5.019+0.336*(UV index)].  County melanoma incidence data, 2006-2010.    
F = 3.07, p = 0.0851. 
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Figure 3.  Simple linear regression of average accumulated UV Index, 2006-2010, 
against latitude.  F = 331, p = 3.33 x 10
-24
.  
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Figure 4.  Simple linear regression of age-adjusted melanoma incidence per 100,000 
inhabitants against age-adjusted male melanoma incidence per 100,000 inhabitants.  
County melanoma incidence data, 2006-2010.  F = 616, p = 1.7 x 10
-30
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Figure 5.  Simple linear regression of age-adjusted melanoma incidence per 100,000 
inhabitants against latitude.  County melanoma incidence data, 2006-2010.  F = 4.16, p = 
0.0466. 
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Figure 6.  Simple linear regression of age-adjusted female melanoma incidence per 
100,000 inhabitants against latitude.  County melanoma incidence data, 2006-2010.  F = 
9.80, p = 0.00286. 
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Figure 7.  Simple linear regression of age-adjusted melanoma incidence per 100,000 
inhabitants against average accumulated UV index, 2006-2010.  County melanoma 
incidence data, 2006-2010.  F = 3.08, p = 0.0851. 
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Figure 8.  Multiple linear regression of age-adjusted American Indian or Alaska Native 
melanoma incidence per 100,000 inhabitants against (a) average accumulated UV index, 
2006-2010: p = 0.0698 (b) latitude: p = 0.0594.  y = -0.446x1 – 0.959x2 + 74.4, r
2
 = 0.377, 
F = 2.42.  
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Figure 9.  Multiple linear regression of age-adjusted male American Indian or Alaska 
Native melanoma incidence per 100,000 inhabitants against (a) average accumulated UV 
index, 2006-2010: p = 0.0217 (b) latitude: p = 0.0263.  y = -0.747x1 – 1.46x2 + 114, r
2
 = 
0.685, F = 5.43.  
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Figure 10.  Multiple linear regression of age-adjusted female American Indian or Alaska 
Native melanoma incidence per 100,000 inhabitants against (a) average accumulated UV 
index, 2006-2010: p = 0.0774 (b) latitude: p = 0.148.  y = -0.525x1 – 1.21x2 + 87.1, r
2
 = 
0.814, F = 6.57.  
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Figure 11.  A plot of age-specific United States melanoma rates by age group per 100,000 inhabitants for males and females.  
Country-wide melanoma incidence data, 2006-2010.
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